Acessibilidade / Reportar erro

Can pregnancy influence the outcome of a malignant thyroid nodule?

Abstracts

The authors report the case of a patient with a thyroid nodule with benign sonographic and cytopathological features that had presented a decrease of more than 50% in three years and changed its pattern during her pregnancy, being diagnosed as papillary carcinoma. It was concluded that pregnancy can either increase the risk for malignant transformation or accelerate the growth of a malignant thyroid nodule, corroborating pre-existing literature data.

Pregnancy; Cancer; Thyroid; Carcinoma; Papillary


Os autores descrevem um nódulo tireoidiano com padrões ultrassonográfico e citopatológico benignos que diminuiu mais de 50% em três anos e se modificou durante a gestação, constatando-se que era carcinoma papilífero. Conclui-se que a gestação pode aumentar o risco de malignização ou acelerar o crescimento de nódulo tireoidiano maligno preexistente, corroborando dados da literatura.

Gestação; Câncer; Tireoide; Carcinoma; Papilífero


CASE REPORT

Can pregnancy influence the outcome of a malignant thyroid nodule?*

Lucy KerrI; Maria Edith Lutz VidigalII; Deborah RozenkwitIII

IMD, Medical Sonographer, Director, IKEP-Instituto Kerr de Ensino e Pesquisa and Sonimage, São Paulo, SP, Brazil

IIMD, Endocrinologist, Member of Sociedade Brasileira de Endocrinologia, São Paulo, SP, Brazil

IIIMD, General Clinician, Trainee in Ultrasonography at IKEP-Instituto Kerr de Ensino e Pesquisa, São Paulo, SP, Brazil

Mailing Address

ABSTRACT

The authors report the case of a patient with a thyroid nodule with benign sonographic and cytopathological features that had presented a decrease of more than 50% in three years and changed its pattern during her pregnancy, being diagnosed as papillary carcinoma. It was concluded that pregnancy can either increase the risk for malignant transformation or accelerate the growth of a malignant thyroid nodule, corroborating pre-existing literature data.

Keywords: Pregnancy; Cancer; Thyroid; Carcinoma; Papillary.

INTRODUCTION

It has been reported that thyroid cancer worsens during pregnancy(1-3) and the worst prognosis would be related to the estrogen receptor alpha-mediated growth factor, whose expression is enhanced in thyroid tumors that run their courses with pregnancy(1).

The present case report describes a thyroid nodule followed-up before, during pregnancy and during lactation, that had presented a 58% decrease in volume since its diagnosis with benign sonographic and cytopathological features(4). Sonographic findings suggesting malignancy only were detected during pregnancy and lactation, when fine-needle aspiration puncture (FNAP) was repeated, demonstrating the presence of a papillary carcinoma. In the present case, the follow-up of the disease progression was critical for the detection of the change in the morphological texture and Doppler patterns, suggesting the lesion malignancy and allowing the adoption of an appropriate approach.

CASE REPORT

A female 31-year-old patient accidentally detected a thyroid nodule, whose first FNAP performed on August 9, 2005 diagnosed a benign hemorrhagic cystic lesion. On November 3, 2005, ultrasonography (US) demonstrated the presence of a mass with mixed echogenicity in the left thyroid lobe (Figure 1), with a benign pattern, and measuring 1.2 × 0.8 × 0.6 cm in the longitudinal, transverse and anteroposterior diameters, respectively, and whose cystic component presented fluid-fluid level suggesting density stratification like in the mixture of water and oil, that is frequently found in cases of intranodular hemorrhage. Doppler study demonstrated a single vessel penetrating the vegetation (Figure 2). A further US study performed on October 6, 2006 revealed a 33% decrease in the nodular volume resulting from partial fluid resorption, while the solid component of the mass remained unchanged. On November 4, 2009, at the 22nd week of pregnancy, US study (Figure 3) revealed a 36% nodule volume decrease resulting from cystic resorption, since the vegetation had tripled in volume and presented hypervascularization, both signs suspicious for malignancy(1,4,5). A second US-guided FNAP was indicated and performed on April 23, 2010, suggesting two hypotheses: pseudo-papilliferous hyperplasia in adeno-matous goiter, or papillary carcinoma. Another sonographic study performed on May 10, 2010, 40 days after delivery, demonstrated that the thyroid nodule had grown 2.3 times in six months, was totally solid, poorly delimited, hypoechogenic and presented microcalcifications, suggesting malignancy(4) (Figure 4). Surgery was performed on May 20, 2010, with diagnosis of a classical pattern of a T1A stage encapsulated papillary carcinoma measuring 0.5 cm.





DISCUSSION

The initial FNAP and US classified the lesion as a benign thyroid nodule, but it was malignant when it was operated three years after the diagnosis. Although the presence of a single vessel in the central region of the mass at the initial Doppler study is considered as a suspicious sign of malignancy by some authors(6,7), others only consider the Doppler pattern as malignant in cases where de mass is completely hypervas-cularized(4,5,8), and the 2008 consensus indicates FNAP for the investigation of such nodules(5). Two hypotheses prevail in the present case: either the nodule was benign and became malignant, or it was already malignant (false-negative at FNAP and US), accelerating its growth during pregnancy. It was observed that the nodule decreased about 58% between the first and the third US studies, the fluid component was resorpted, and suspicious signs appeared: a three-fold increase in size and hypervascularization of the solid component. It is more likely that malignancy was present since the beginning, and the pregnancy contributed to the accelerated growth of the mass. The US follow-up allowed the investigators to raise the suspicion of malignancy that was confirmed by FNAP. The authors conclude that the pregnancy may have influenced the growth of the pre-existing malignant thyroid nodule, and that the evolutive follow-up was fundamental to the correct diagnosis in the present case.

REFERENCES

  • 1. Vannucchi G, Perrino M, Rossi S, et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 2010;162:145-51.
  • 2. Vini L, Hyer S, Pratt B, et al. Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 1999;140:404-6.
  • 3. Wémeau JL, Do Cao C. Thyroid nodule, cancer and pregnancy. Ann Endocrinol (Paris). 2002;63:438-42.
  • 4. Kerr L. High-resolution thyroid ultrasound: the value of color Doppler. Ultrasound Q. 1994;12:21-43.
  • 5. Cibas ES, Alexander EK, Benson CB, et al. Indications for thyroid FNA and pre-FNA requirements: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:390-9.
  • 6. Chammas MC, Gerhard R, Oliveira IRS, et al. Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound. Otolaryngol Head Neck Surg. 2005;132:874-82.
  • 7. Lagalla R, Caruso G, Novara V, et al. Analisi flussimetrica nella patologia tiroidea: ipotesi di integrazione con lo studio qualitativo con color-Doppler. Radiol Med. 1993;85:606-10.
  • 8. Faria MAS, Casulari LA. Comparação das classificações dos nódulos de tireoide ao Doppler colorido descritas por Lagalla e Chammas. Arq Bras Endocrinol Metab. 2009;53:811-7.
  • Endereço para correspondência:
    Dra. Lucy Kerr
    Avenida Brigadeiro Luís Antônio, 2504, 2º andar, conjunto 21/22, Jardim Paulista
    São Paulo, SP, Brasil, 01402-000
    E-mail:
  • *
    Trabalho realizado no IKEP-Instituto Kerr de Ensino e Pesquisa, São Paulo, SP, Brasil.
  • Publication Dates

    • Publication in this collection
      16 Mar 2012
    • Date of issue
      Feb 2012

    History

    • Received
      12 Dec 2010
    • Accepted
      11 Aug 2011
    Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem Av. Paulista, 37 - 7º andar - conjunto 71, 01311-902 - São Paulo - SP, Tel.: +55 11 3372-4541, Fax: 3285-1690, Fax: +55 11 3285-1690 - São Paulo - SP - Brazil
    E-mail: radiologiabrasileira@cbr.org.br